Delivery Order SPE2DB25D3306-SPE2DB26FUAPN
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,977.61 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 30 mg capsules (100 count) on August 22, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price delivery order was issued under a child contract arrangement with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $1,613.66 delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Lisdexamfetamine 60 mg capsules (90-count units). This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of November 6, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Lisdexamfetamine 30 mg capsules (90-count units) with a ceiling value of $3,103.04. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 17, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Lisdexamfetamine 30 mg capsules (100-count units) with a ceiling value of $1,070.16. This firm fixed price delivery order represents a competitive award with no set-aside designation and is expected to be completed by September 9, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Lisdexamfetamine 40 mg capsules (90-count units) with a contract ceiling value of $1,339.45. This is a firm fixed price delivery order with no set-aside designation, issued competitively to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The place of performance is located at the contractor's corporate office in Conshohocken, PA, with an...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Lisdexamfetamine 50 mg capsules (100-count units) valued at $1,426.80, with completion scheduled for September 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The contract represents a continuation of the pharmaceutical supply relationship...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Lisdexamfetamine 70 mg capsules (100-count) with a ceiling value of $1,474.24. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The order is scheduled for completion by September 10, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of lisdexamfetamine 40 mg capsules (100-count units) with a ceiling value of $1,886.66. This firm fixed-price delivery order, with an ultimate completion date of May 21, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,025.65 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 30 mg capsules (100-count units). The contract was competitively awarded without set-aside provisions and is priced on a firm fixed-price basis, with an ultimate completion date of September 24, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Lisdexamfetamine 30 mg capsules in quantities of 100 units. This competitively awarded, non-set-aside delivery order carries a ceiling value of $2,125.58 and has an ultimate completion date of July 30, 2025. AmerisourceBergen Drug Corp will perform this contract from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB26FUAPNDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Lisdexamfetamine 30 mg capsules (100 count) with a ceiling value of $1,260.57. This firm fixed-price delivery order, which is not set-aside for small businesses or other designated groups, is scheduled for completion by November 5, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a single transaction under the company's broader pharmaceutical supply relationship with the federal government. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion agreement running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, is well-positioned to fulfill federal medical procurement requirements through this arrangement, which enables the company to supply a wide range of pharmaceutical products and medical supplies to support Defense Health Agency operations, the U.S. Coast Guard, and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 11/4/25 |